Telehealth includes health care services provided using audio and video technology. Telehealth was originally developed to provide basic care to rural and underserved patients. Higher rates of use of telehealth are now standard in many practices since the coronavirus disease 2019 pandemic. Increasing emphases on patient satisfaction, providing efficient and quality care, and minimizing costs have also led to higher telehealth implementation. Patients and providers have enjoyed the benefits of telehealth, but widespread adoption has been hindered by regulatory, legal, and reimbursement barriers. Recent legislative initiatives have advocated for further telehealth advancements, especially with the rapid implementation of telehealth in the times of coronavirus disease 2019.

ndometrial cancer is the most common cancer of the female reproductive system in the United States and developed world. 1,2 The American Cancer Society estimates 65,950 new cases of uterine cancer (endometrial cancers and uterine sarcomas) in 2022. 1 This is an increase of 6.6% from 2019. 3 Risk factors for endometrial cancer include advancing age, early menarche, nulliparity, late menopause, hormone replacement therapy, obesity, type 2 diabetes, polycystic ovarian syndrome, and genetic disorders such as Lynch syndrome. 4 The average age of diagnosis is 60 years. 1 The most common clinical presentation of a woman with endometrial cancer is abnormal postmenopausal vaginal bleeding. 4 Physical examination fi ndings are limited, because peritoneal abnormalities and adnexal masses are more indicative of advanced disease. 4 At the time this article was written, Lacey King was a student in the

In small clinical trials, dehydroepiandrosterone (DHEA) has been found to relieve symptoms associated with postmenopausal conditions and infertility in women. DHEA may provide a cost-effective alternative to typical hormone therapies. Because of a lack of long-term and large-scale studies, only intravaginal DHEA supplementation is approved and recommended for treatment. Further investigation of DHEA supplementation is needed and encouraged to determine its safety and effectiveness.